Clinical Trial Update: Celebrex In Acute Gouty Arthritis Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for celecoxib (Celebrex) in acute gouty arthritis completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Gouty Arthritis

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Arthritis, Gouty | Phase 3 | Status: COMPLETED | Results posted: 2011-02-24